Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Greenwich LifeSciences, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 39 | 42 | +3 |
| Shares | 1.14M | 1.18M | +40.4K (+3.5%) |
| Value | $16.4M | $13.3M | −$3.13M (−19.1%) |
New holders (6)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 15,070 | $169.2K | 0.00% |
| Brown Brothers Harriman & Co | 4,000 | $44.9K | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,300 | $14.6K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,076 | $12.1K | 0.00% |
| Hopwood Financial Services, Inc. | 50 | $562 | 0.00% |
| SBI Securities Co., Ltd. | 30 | $337 | 0.00% |
Sold out (3)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Millennium Management LLC | 10,638 | $152.9K |
| Capital Performance Advisors LLP | 1 | $14 |
| Capital Advisors, Ltd. LLC | 1 | $0 |